Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions
Blood pressure and bone metabolism appear to share commonalities in their physiologic regulation. Specific antihypertensive drug classes may also influence bone mineral density. However, current evidence from existing observational studies and randomised trials is insufficient to establish causal as...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer
2021
|
| _version_ | 1797076618315825152 |
|---|---|
| author | Canoy, D Harvey, NC Prieto-Alhambra, D Cooper, C Meyer, HE Åsvold, BO Nazarzadeh, M Rahimi, K |
| author_facet | Canoy, D Harvey, NC Prieto-Alhambra, D Cooper, C Meyer, HE Åsvold, BO Nazarzadeh, M Rahimi, K |
| author_sort | Canoy, D |
| collection | OXFORD |
| description | Blood pressure and bone metabolism appear to share commonalities in their physiologic regulation. Specific antihypertensive drug classes may also influence bone mineral density. However, current evidence from existing observational studies and randomised trials is insufficient to establish causal associations for blood pressure and use of blood pressure–lowering drugs with bone health outcomes, particularly with the risks of osteoporosis and fractures. The availability and access to relevant large-scale biomedical data sources as well as developments in study designs and analytical approaches provide opportunities to examine the nature of the association between blood pressure and bone health more reliably and in greater detail than has ever been possible. It is unlikely that a single source of data or study design can provide a definitive answer. However, with appropriate considerations of the strengths and limitations of the different data sources and analytical techniques, we should be able to advance our understanding of the role of raised blood pressure and its drug treatment on the risks of low bone mineral density and fractures. As elevated blood pressure is highly prevalent and blood pressure–lowering drugs are widely prescribed, even small effects of these exposures on bone health outcomes could be important at a population level. |
| first_indexed | 2024-03-07T00:06:16Z |
| format | Journal article |
| id | oxford-uuid:77a62030-5469-4546-a37f-ea6b5b9c7b58 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:06:16Z |
| publishDate | 2021 |
| publisher | Springer |
| record_format | dspace |
| spelling | oxford-uuid:77a62030-5469-4546-a37f-ea6b5b9c7b582022-03-26T20:25:33ZElevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directionsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:77a62030-5469-4546-a37f-ea6b5b9c7b58EnglishSymplectic ElementsSpringer2021Canoy, DHarvey, NCPrieto-Alhambra, DCooper, CMeyer, HEÅsvold, BONazarzadeh, MRahimi, KBlood pressure and bone metabolism appear to share commonalities in their physiologic regulation. Specific antihypertensive drug classes may also influence bone mineral density. However, current evidence from existing observational studies and randomised trials is insufficient to establish causal associations for blood pressure and use of blood pressure–lowering drugs with bone health outcomes, particularly with the risks of osteoporosis and fractures. The availability and access to relevant large-scale biomedical data sources as well as developments in study designs and analytical approaches provide opportunities to examine the nature of the association between blood pressure and bone health more reliably and in greater detail than has ever been possible. It is unlikely that a single source of data or study design can provide a definitive answer. However, with appropriate considerations of the strengths and limitations of the different data sources and analytical techniques, we should be able to advance our understanding of the role of raised blood pressure and its drug treatment on the risks of low bone mineral density and fractures. As elevated blood pressure is highly prevalent and blood pressure–lowering drugs are widely prescribed, even small effects of these exposures on bone health outcomes could be important at a population level. |
| spellingShingle | Canoy, D Harvey, NC Prieto-Alhambra, D Cooper, C Meyer, HE Åsvold, BO Nazarzadeh, M Rahimi, K Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions |
| title | Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions |
| title_full | Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions |
| title_fullStr | Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions |
| title_full_unstemmed | Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions |
| title_short | Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions |
| title_sort | elevated blood pressure antihypertensive medications and bone health in the population revisiting old hypotheses and exploring future research directions |
| work_keys_str_mv | AT canoyd elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections AT harveync elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections AT prietoalhambrad elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections AT cooperc elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections AT meyerhe elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections AT asvoldbo elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections AT nazarzadehm elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections AT rahimik elevatedbloodpressureantihypertensivemedicationsandbonehealthinthepopulationrevisitingoldhypothesesandexploringfutureresearchdirections |